Enfusion, Inc.
ENFN
ENFN was delisted on the 17th of April, 2025.
76 hedge funds and large institutions have $828M invested in Enfusion, Inc. in 2023 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 36 increasing their positions, 15 reducing their positions, and 9 closing their positions.
1,361% more call options, than puts
Call options by funds: $263K | Put options by funds: $18K
140% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 15
33% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 9
11% more capital invested
Capital invested by funds: $746M → $828M (+$82M)
1% more funds holding
Funds holding: 75 → 76 (+1)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$8.18M |
| 2 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$6.77M |
| 3 |
NCM
Nellore Capital Management
Redwood City,
California
|
+$5.67M |
| 4 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$3.48M |
| 5 |
ACM
Ararat Capital Management
Westport,
Connecticut
|
+$2.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$4.13M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.36M |
| 3 |
CC
Clearline Capital
New York
|
-$2.39M |
| 4 |
ICM
Irenic Capital Management
New York
|
-$1.43M |
| 5 |
Goldman Sachs
New York
|
-$821K |
ENFN Hedge Fund Activity: Q4 2023 in Review
76 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q4 2023, worth a combined $828M — up 11% from $746M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ENFN positions and 9 closed out — a net gain of 3 holders — while 36 added to existing stakes and 15 trimmed.
The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $8.18M. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $4.13M sold.
- 76 institutional investors held Enfusion, Inc. (ENFN) as of Q4 2023, up from 75 in Q3 2023.
- Funds reported $828M of Enfusion, Inc. stock for Q4 2023, up 11% quarter-over-quarter.
- 12 funds opened new Enfusion, Inc. positions in Q4 2023 and 9 closed out, a net change of +3 holders.
- The largest Enfusion, Inc. buyer in Q4 2023 was T. Rowe Price Investment Management, an estimated $8.18M added.
- The largest Enfusion, Inc. seller in Q4 2023 was Hudson Bay Capital Management, an estimated $4.13M sold.
Based on aggregated 13F filings for Q4 2023.